CROs offer new COVID-19 services

By The Science Advisory Board staff writers

August 6, 2020 -- Contract research organizations (CROs) Caprion-HistoGeneX and Viroclinics have formed a strategic partnership to develop therapeutics and prophylactic solutions targeting infectious diseases like COVID-19.

Through the partnership, the companies will leverage their respective expertise in contract research serving the pharmaceutical and biotechnology communities to offer a full suite of specialized services to support vaccine and antiviral clinical and preclinical studies. This will include research sites in the Netherlands, Canada, U.S., Belgium, U.K., Australia, and China.

The companies will provide an integrated service experience for customers with services covering all aspects of vaccine and antiviral development. This includes preclinical and in vitro research models to deployment of custom-developed and off-the-shelf functional efficacy assays. The partnership will also extend global access to clinical sample processing facilities with operational and logistical services included in sample management and sampling kits.

Eurofins DiscoverX expands program with Catalent
Eurofins DiscoverX has expanded its contract research organization certification program for bioassays with Catalent Biologics as the North American provider.
Florida CRO expands drug screening and manufacturing
Florida-based contract research organization (CRO) Alchem Laboratories is constructing a new building to grow its screening and chemical trail manufacturing...

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
ESMO Virtual Congress 2020
September 14-29
2020 ACCP Annual Meeting
September 20-22
BioProcess International West
September 21-25
BioProcess International
September 21-25
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter